Skip to main content

Apollo Endosurgery, Inc.

APENDelisted Apr 4, 2023
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001251769

Apollo Endosurgery, Inc. was delisted on Apr 4, 2023; its insiders filed their last Form 4 on Apr 4, 2023; 90 institutions reported holding it in 13F filings for Q1 2023, worth $442.4M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Apollo Endosurgery, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of APEN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders7271−1
Shares28.3M29.6M+1.23M (+4.3%)
Value$238.8M$178.8M−$60.0M (−25.1%)

New holders (13)

Institutions that held Apollo Endosurgery, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to APEN in Q1 2022
InstitutionSharesValue% of portfolio
Invesco Ltd.311,028$1.88M0.00%
Laurion Capital Management LP50,100$303.0K0.01%
Bank of New York Mellon Corp48,310$293.0K0.00%
Hussman Strategic Advisors, Inc.26,000$157.0K0.03%
Man Group plc24,164$146.0K0.00%
Charles Schwab Investment Management Inc17,198$105.0K0.00%
PDT Partners, LLC14,717$89.0K0.01%
Mirabella Financial Services LLP13,151$80.0K0.01%
Sciencast Management LP13,876$80.0K0.02%
Cambridge Investment Research Advisors, Inc.11,147$67.0K0.00%
Waypoint Capital Advisors, LLC10,000$58.0K0.03%
Simplex Trading, LLC8,470$51.0K0.00%
Tower Research Capital LLC (TRC)71$00.00%

Sold out (14)

Institutions that held Apollo Endosurgery, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.